您的位置:首页 > 会议日程
李长贤 Changxian Li
分享到:
江苏省人民医院(南京医科大学第一附属医院) The First Affiliated Hospital of Nanjing Medical University | 肝胆外科

Deputy Chief Physician, Associate Professor, and Master's Supervisor at Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University). He graduated with a Ph.D. from the Department of Surgery at the University of Hong Kong and mainly engages in clinical and basic research work in the field of hepatobiliary surgery and liver transplantation. He has published over 30 SCI papers as the first author or corresponding author (including co-authors) in internationally renowned journals such as Journal of Hepatology, Nature Communications, Advanced Science, Molecular Cancer, Annals of Surgery, Oncogene, Journal of Experimental & Clinical Cancer Research, Cellular and Molecular Gastroenterology and Hepatology, Liver International, Annals of Surgical Oncology, and Transplantation. He serves as a member of the International Liver Transplantation society and The Transplant society, as well as the Secretary of the Hepatocellular Carcinoma Professional Committee of Jiangsu Anti-Cancer Association, a member of the Tumor Surgery Committee of Jiangsu Physicians Association, a member of the Hepatobiliary Group of the Oncology Branch of Jiangsu Medical Association, a young member of the Organ Transplantation Branch of Jiangsu Medical Association, and a young member of the Oncology Branch of Jiangsu Medical Association, and the Secretary of the Hepatobiliary Group of Nanjing Medical Association. In 2018, he was awarded the "Double Creative Doctor" in Jiangsu Province, and in 2022, he was selected as a third-tier training object of the 333 High-Level Talents in Jiangsu Province. He received the first prize of the Science and Technology Progress Award from the Chinese Medical Association in 2014, the first prize of the Medical Science and Technology Award from Jiangsu Province in 2019, and the third prize of the Science and Technology Progress Award from the Chinese Medical Association in 2019. In 2011 and 2016, he successively received the "Rising Star" award from the International Liver Transplantation Association. In addition, he has received the "Trainee and Mentor Award" (2011, 2013, 2014, 2015), "Young Investigator" award (2018, 2020), and "Travel Award" (2010) from the Transplant society and the International Liver Transplantation society.


讲座视频:0

论文摘要:1

16

0

0

日期 时间 会场 Session 角色 讲题
2024-11-23 09:45-10:00 分会场-翡翠宴会厅 (B) Jade Ballroom (B)

肝移植 Liver

讲者 Speaker Neutrophils PR3 promote hepatic ischemia reperfusion injury by inducing hepatocytes PANoptosis through FGFR4/AMPK pathwayNeutrophils PR3 promote hepatic ischemia reperfusion injury by inducing hepatocytes PANoptosis through FGFR4/AMPK pathway